|
Willingness-to-pay amounts in 2002 dollars for health states |
||||
| a. For each health state avoided |
||||
| Median |
Mean |
5th – 95th percentile |
Range (minimum – maximum) |
|
|
|
||||
| Influenza in 1-year old child* |
175 |
469 |
0 – 1500 |
0 – 10,000 |
| Influenza in 14-year old child* |
100 |
288 |
0 – 1000 |
0 – 5,000 |
| Guillain-Barré Syndrome in 1-year old child |
5,000 |
28,579 |
100 – 100,000 |
10 – 1,000,000 |
| Severe allergic reaction in 1-year old child |
400 |
4,968 |
0 – 10,000 |
0 – 200,000 |
| b. For risk reductions |
||||
| Median |
Mean |
5th – 95th percentile |
Range (minimum – maximum) |
|
|
|
||||
| Influenza vaccine with no risk of Guillain-Barré Syndrome after vaccination |
100 |
341 |
3 – 2,000 |
0 – 5,000 |
| Influenza vaccine with no risk of severe allergic reaction after vaccination |
50 |
223 |
10 – 1,000 |
0 – 5,000 |
|
*P-value < .0001 using the sign test to assess whether WTP for influenza in a 1-year-old child is greater than WTP for influenza in a 14-year-old. | ||||
Prosser et al. Health and Quality of Life Outcomes 2005 3:18 doi:10.1186/1477-7525-3-18 |
||||